1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CXCR
  4. CXCR Inhibitors

CXCR Inhibitors

CXCR

CXCR1

CXCR2

CXCR3

CXCR4

CXCR7

CXCR6

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

CXCR Inhibitors, Agonists, Antagonists & Modulators
Product Name CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 CXCR6 Purity
Plerixafor        
125I-CXCL12-CXCR4, IC50: 44 nM
    ≥98.0%
SB225002    
125I-IL-8-CXCR2, IC50: 22 nM (in CHO cell membrane)
        99.78%
AMG 487      
125I-IP10-CXCR3, IC50: 8 nM
125I-ITAC-CXCR3, IC50: 8.2 nM
      99.65%
Navarixin  
Cynomolgus CXCR1, Kd: 41 nM
125I-CXCL8-CXCR1, IC50: 43 nM
Mouse CXCR2, Kd: 0.2 nM
Rat CXCR2, Kd: 0.2 nM
Cynomolgus CXCR2, Kd: 0.08 nM
125I-CXCL8-CXCR2, IC50: 0.97 nM
        99.13%
Reparixin  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
        99.98%
Ladarixin sodium  
CXCR1
CXCR2
        99.15%
AZD-5069    
125I-IL-8-CXCR2
        99.63%
Plerixafor octahydrochloride        
125I-CXCL12-CXCR4, IC50: 44 nM
    ≥98.0%
Motixafortide        
CXCR4, IC50: ~1 nM
    99.03%
Mavorixafor trihydrochloride        
125I-SDF-CXCR4, IC50: 13 nM
    ≥98.0%
TAK-779      
mCXCR3, IC50: 369 nM (in PBMCs)
      ≥98.0%
SX-682  
CXCR1
CXCR2
        98.52%
SCH 546738      
Human CXCR3, Ki: 0.4 nM
      99.23%
NUCC-390 dihydrochloride        
CXCR4
    99.59%
IT1t dihydrochloride        
CXCL12/CXCR4, IC50: 2.1 nM
    99.89%
NBI-74330      
[125I]CXCL10-CXCR3, Ki: 1.5 nM (in CXCR3-CHO cell membranes)
[125I]CXCL11-CXCR3, Ki: 3.2 nM (in CXCR3-CHO cell membranes)
      99.23%
Reparixin L-lysine salt  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
        99.93%
Balixafortide TFA        
CXCR4, IC50: <10 nM
    98.19%
Burixafor hydrobromide        
CXCR4
    ≥98.0%
Baohuoside I        
CXCR4
    99.70%
LY2510924        
125I-SDF-1α-CXCR4, IC50: 79.7 pM
125I-SDF-1α-CXCR4, Ki: 49.5 pM
    ≥98.0%
WZ811        
CXCR4, EC50: 0.3 nM
    ≥99.0%
AMD 3465 hexahydrobromide        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
    ≥98.0%
Danirixin    
CXCL8-CXCR2, IC50: 12.5 nM
        98.21%
CXCR2-IN-1    
CXCR2, pIC50: 9.3
        99.26%
MSX-122        
CXCR4/CXCL12, IC50: ~10 nM
    98.29%
USL311        
CXCR4
    99.97%
PS372424 hydrochloride      
Human CXCR3
      ≥98.0%
Elubrixin tosylate    
CXCR2
        99.74%
ALX 40-4C Trifluoroacetate        
SDF-1-CXCR4, Ki: 1 μM
    95.90%
CXCR7 modulator 2          
CXCR7, Ki: 13 nM
  ≥98.0%
VUF11207 fumarate          
CXCR7, pKi: 8.1
  98.92%
SRT3190    
CXCR2
        99.32%
SCH 563705  
CXCR1, Ki: 3 nM
CXCR1, IC50: 7.3 nM
CXCR2, Ki: 1 nM
CXCR2, IC50: 1.3 nM
Mouse CXCR2, IC50: 5.2 nM
        98.20%
TC14012        
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
  99.43%
FC131 TFA        
125I-SDF-1-CXCR4, IC50: 4.5 nM
    99.87%
CXCR2-IN-2  
CXCR1, IC50: 3.8 μM
CXCR2, IC50: 5.2 nM
        99.35%
Nicotinamide N-oxide    
CXCR2
        99.93%
SRT3109    
CXCR2, pIC50: 8.2
        99.82%
CXCR7 modulator 1          
CXCR7, Ki: 9 nM
  99.67%
SB-265610    
CXCR2
        ≥99.0%
UNBS5162
CXCL
            99.92%
IT1t        
CXCL12/CXCR4, IC50: 2.1 nM
   
ML339            
CXCR6, IC50: 140 nM
ALX 40-4C        
SDF-1-CXCR4, Ki: 1 μM
   
NUCC-390        
CXCR4
   
PS372424      
Human CXCR3
     
Mavorixafor        
125I-SDF-CXCR4, IC50: 13 nM
   
KRH-3955 hydrochloride        
SDF-1α-CXCR4, IC50: 0.61 nM
   
AMG 487 (S-enantiomer)      
CXCR3
      98.92%
AMD 3465        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
   
Balixafortide        
CXCR4, IC50: <10 nM
   
Elubrixin    
CXCR2
       
MSX-127        
CXCR4
   
CTCE-9908        
CXCR4
   
CTCE-9908 TFA        
CXCR4
   
TC14012 TFA        
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
 
ATI-2341        
CXCR4, EC50: 194 nM (in CCRF-CEM cells)
   
Corydalmine    
CXCR2
       
CXCR4 antagonist 1        
CXCR4
   
MSX-130        
CXCR4
   
FC131        
125I-SDF-CXCR4, IC50: 4.5 nM